StockData
MindWalk Holdings Corp. logo

MindWalk Holdings Corp. (HYFT) stock

HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 20-F on Jul 23, 2026Score 7/30
$0.90−0.01 (-0.74%)

Close on Nov 18, 2026Market cap $42.04MP/E –Yield –

MindWalk revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MindWalk's revenue for the twelve months ending Jul 31, 2026 was C$16.23M, up 43.4% year over year. For fiscal 2026 it was C$15.56M, up 46.4% from the year before. The highest annual figure on record is C$20.67M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2026Apr 30, 2026C$15.56M+46.4%
FY2025Apr 30, 2025C$10.63M+3.4%
FY2024Apr 30, 2024C$10.28M-50.3%
FY2023Apr 30, 2023C$20.67M+6.7%
FY2022Apr 30, 2022C$19.36M+8.1%
FY2021Apr 30, 2021C$17.91M+27.4%
FY2020Apr 30, 2020C$14.06M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026C$3.83M+21.3%
Q4 FY2026CQ1 2026Apr 30, 2026C$4.12M+49.8%
Q3 FY2026CQ4 2025Jan 31, 2026C$4.16M+52.4%
Q2 FY2026CQ3 2025Oct 31, 2025C$4.12M+53.9%
Q1 FY2026CQ2 2025Jul 31, 2025C$3.16M+27.8%
Q4 FY2025CQ1 2025Apr 30, 2025C$2.75M-57.5%
Q3 FY2025CQ4 2024Jan 31, 2025C$2.73M-56.1%
Q2 FY2025CQ3 2024Oct 31, 2024C$2.68M-56.4%
Q1 FY2025CQ2 2024Jul 31, 2024C$2.47M-56.5%
Q4 FY2024CQ1 2024Apr 30, 2024C$6.46M+14.9%
Q3 FY2024CQ4 2023Jan 31, 2024C$6.22M+20.3%
Q2 FY2024CQ3 2023Oct 31, 2023C$6.15M+18.6%
Q1 FY2024CQ2 2023Jul 31, 2023C$5.69M–
Q4 FY2023CQ1 2023Apr 30, 2023C$5.62M–
Q3 FY2023CQ4 2022Jan 31, 2023C$5.17M–
Q2 FY2023CQ3 2022Oct 31, 2022C$5.18M–

More MindWalk figures

See a number that looks wrong?